Drug
Radiprodil
Radiprodil: highest development phase Phase 3, developed by GRIN Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GRIN Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Radiprodil NCT07224581 | Phase 3 | GRIN-related Neurodevelopmental Disorder |
Latest
No recent events.
Follow Radiprodil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.